Waterloo Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.94M Buy
304,684
+7,548
+3% +$150K 0.33% 68
2026
Q1
$5.71M Buy
297,136
+32,774
+12% +$646K 0.4% 63
2025
Q4
$5.01M Buy
264,362
+2,764
+1% +$51.2K 0.36% 64
2025
Q3
$4.88M Buy
261,598
+6,668
+3% +$125K 0.36% 65
2025
Q2
$4.7M Buy
254,930
+12,894
+5% +$229K 0.38% 57
2025
Q1
$4.23M Buy
242,036
+21,319
+10% +$359K 0.39% 62
2024
Q4
$3.82M Buy
220,717
+357
+0.2% +$6.52K 0.4% 63
2024
Q3
$4.1M Sell
220,360
-25,982
-11% -$438K 0.45% 54
2024
Q2
$3.79M Buy
246,342
+16,474
+7% +$235K 0.46% 56
2024
Q1
$3.4M Buy
229,868
+67,254
+41% +$931K 0.43% 56
2023
Q4
$2.32M Buy
+162,614
New +$2.31M 0.38% 68

Other funds holding SBRA

Waterloo Capital's SBRA Position: Q2 2026 in Review

Waterloo Capital increased its Sabra Healthcare REIT (SBRA) stake by 2.5% in Q2 2026, buying an estimated $150K and bringing the position to 304,684 shares worth $5.94M. The position accounts for 0.33% of the portfolio, ranked #68.

Waterloo Capital first reported a position in SBRA in Q4 2023 and has held it in 11 quarters since. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Waterloo Capital held 304,684 shares of Sabra Healthcare REIT worth $5.94M as of Q2 2026.
  • Waterloo Capital bought 7,548 Sabra Healthcare REIT shares in Q2 2026, an estimated $150K.
  • Sabra Healthcare REIT made up 0.33% of Waterloo Capital's portfolio in Q2 2026, its #68 holding.
  • Waterloo Capital first reported a position in Sabra Healthcare REIT in Q4 2023 and has held it in 11 quarters since.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.